The program will allow certain Medicare enrollees access to GLP-1 drugs for just $50 a month.
A conversation with Harvard Kennedy School experts Iris Bohnet and Siri Chilazi on increasing diversity with systems, not programs. Amid the backlash against diversity, equity, and inclusion (DEI) ...